Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reelin-immunoreactive neurons in the adult vertebrate pallium.

Journal of chemical neuroanatomy·2001

Same author

Ionic films on vicinal metal surfaces: enhanced binding due to charge modulation.

Physical review letters·2001

Same author

Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis.

The American journal of medicine·2001

Same author

Structure and mesomorphism of neodymium(III) alkanoates.

Inorganic chemistry·2001

Same author

[Trabeculotomy in congenital glaucoma: comparison to goniotomy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2001

Same author

Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves.

Vaccine·2001

Search research articles

Related Experiment Videos

Evidence-based medicine for diabetes educators: a pilot study.

G Meyer¹, S Köpke, M Lenz

¹University of Hamburg, Unit of Health Sciences and Education, Hamburg, Germany. gabriele.meyer@uni-hamburg.de

Diabetic Medicine : a Journal of the British Diabetic Association

|May 19, 2007

Summary

A pilot study found that short Evidence-Based Medicine (EBM) courses for diabetes educators are feasible but do not significantly improve knowledge or skills. More intensive training is needed for a clinically relevant impact.

Related Experiment Videos

Area of Science:

Medical Education
Health Literacy
Diabetes Care

Background:

Health professionals increasingly communicate research to patients.
Diabetes educators are crucial for patient information.
Evidence-Based Medicine (EBM) training is lacking for German diabetes educators.

Purpose of the Study:

To assess the feasibility of a short EBM module in diabetes educator training.
To evaluate the impact of EBM training on knowledge and skills.

Main Methods:

A pilot study involved 121 diabetes educator trainees.
EBM modules were delivered in 1- to 3-day courses.
Knowledge and skills assessed via questionnaire on study design, effect size, and patient communication.

Main Results:

Participants found courses useful but too short.
Mean EBM knowledge scores increased from 5 to 7 (P < 0.001).
Assessment showed substantial to almost perfect inter-rater agreement on most items.

Conclusions:

EBM education for diabetes educators is feasible.
Short courses yielded a statistically significant but not clinically relevant increase in knowledge.
Intensified EBM training formats are required for diabetes educators.